These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16793385)

  • 1. Assays for nonhomologous end joining in extracts.
    Budman J; Chu G
    Methods Enzymol; 2006; 408():430-44. PubMed ID: 16793385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybrid joint formation in human V(D)J recombination requires nonhomologous DNA end joining.
    Raghavan SC; Tong J; Lieber MR
    DNA Repair (Amst); 2006 Feb; 5(2):278-85. PubMed ID: 16275127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Processing of DNA for nonhomologous end-joining by cell-free extract.
    Budman J; Chu G
    EMBO J; 2005 Feb; 24(4):849-60. PubMed ID: 15692565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro nonhomologous DNA end joining system.
    Ma Y; Lieber MR
    Methods Enzymol; 2006; 408():502-10. PubMed ID: 16793389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism of vertebrate nonhomologous DNA end joining and its role in V(D)J recombination.
    Lieber MR; Ma Y; Pannicke U; Schwarz K
    DNA Repair (Amst); 2004; 3(8-9):817-26. PubMed ID: 15279766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Processing of DNA for nonhomologous end-joining is controlled by kinase activity and XRCC4/ligase IV.
    Budman J; Kim SA; Chu G
    J Biol Chem; 2007 Apr; 282(16):11950-9. PubMed ID: 17272270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA end joining activity is reduced in Alzheimer's disease.
    Shackelford DA
    Neurobiol Aging; 2006 Apr; 27(4):596-605. PubMed ID: 15908050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of nonhomologous DNA end joining, conservative homologous recombination, and single-strand annealing in the cell cycle-dependent repair of DNA double-strand breaks induced by H(2)O(2) in mammalian cells.
    Frankenberg-Schwager M; Becker M; Garg I; Pralle E; Wolf H; Frankenberg D
    Radiat Res; 2008 Dec; 170(6):784-93. PubMed ID: 19138034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of DNA-dependent protein kinase-mediated DNA end joining by two-photon fluorescence cross-correlation spectroscopy.
    Merkle D; Block WD; Yu Y; Lees-Miller SP; Cramb DT
    Biochemistry; 2006 Apr; 45(13):4164-72. PubMed ID: 16566590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficient nonhomologous end-joining activity in cell-free extracts from Brca1-null fibroblasts.
    Zhong Q; Boyer TG; Chen PL; Lee WH
    Cancer Res; 2002 Jul; 62(14):3966-70. PubMed ID: 12124328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct mechanisms of nonhomologous end joining in the repair of site-directed chromosomal breaks with noncomplementary and complementary ends.
    Willers H; Husson J; Lee LW; Hubbe P; Gazemeier F; Powell SN; Dahm-Daphi J
    Radiat Res; 2006 Oct; 166(4):567-74. PubMed ID: 17007549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-homologous end-joining for repairing I-SceI-induced DNA double strand breaks in human cells.
    Honma M; Sakuraba M; Koizumi T; Takashima Y; Sakamoto H; Hayashi M
    DNA Repair (Amst); 2007 Jun; 6(6):781-8. PubMed ID: 17296333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-related nonhomologous end joining activity in rat neurons.
    Sharma S
    Brain Res Bull; 2007 Jun; 73(1-3):48-54. PubMed ID: 17499636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pol3 is involved in nonhomologous end-joining in Saccharomyces cerevisiae.
    Chan CY; Galli A; Schiestl RH
    DNA Repair (Amst); 2008 Sep; 7(9):1531-41. PubMed ID: 18606574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role and regulation of human XRCC4-like factor/cernunnos.
    Dahm K
    J Cell Biochem; 2008 Aug; 104(5):1534-40. PubMed ID: 18335491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Backup pathways of NHEJ are suppressed by DNA-PK.
    Perrault R; Wang H; Wang M; Rosidi B; Iliakis G
    J Cell Biochem; 2004 Jul; 92(4):781-94. PubMed ID: 15211575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the TrkA or TrkB receptor tyrosine kinase alters the double-strand break (DSB) repair capacity of SY5Y neuroblastoma cells.
    Schulte JH; Kuhfittig-Kulle S; Klein-Hitpass L; Schramm A; Biard DS; Pfeiffer P; Eggert A
    DNA Repair (Amst); 2008 Oct; 7(10):1757-64. PubMed ID: 18678285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased but error-prone nonhomologous end joining in immortalized lymphoblastoid cell extracts from adult cancer patients with late radionecrosis.
    Tan WM; Paterson MC; Koo GC; Li HH; Price A; Loong SL
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):178-85. PubMed ID: 18722268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of double-strand break non-homologous end-joining by cisplatin adducts in human cell extracts.
    Diggle CP; Bentley J; Knowles MA; Kiltie AE
    Nucleic Acids Res; 2005; 33(8):2531-9. PubMed ID: 15872216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of illegitimate V(D)J recombination or microhomology-mediated nonhomologous end-joining in the formation of intragenic deletions of the Notch1 gene in mouse thymic lymphomas.
    Tsuji H; Ishii-Ohba H; Katsube T; Ukai H; Aizawa S; Doi M; Hioki K; Ogiu T
    Cancer Res; 2004 Dec; 64(24):8882-90. PubMed ID: 15604248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.